PRAX
PRAX
NASDAQ · Biotechnology

Praxis Precision Medicines I

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$311.92
+17.27 (+5.86%)
As of Mar 25, 9:47 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 2 9%
Sell 1 4%
Price Target
Analyst Price Target -93.8% upside
Low Target $15.93
Average Target $19.45
High Target $25.00
Current Price $311.92
Current
$311.92
Target
$19.45
$15.93 $19.45 avg $25.00
Scenario Analysis
Bear Case
$15.93
-94.9%
Low target
Base Case
$19.45
-93.8%
Avg target
Bull Case
$25.00
+-92.0%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$335.75
-7.1% from high
52-Week Low
$26.70
+1,068.2% from low
50-Day SMA
$296.27
+5.3% vs SMA
200-Day SMA
$133.67
+133.4% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$19.45
-94.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%